A new press release from the FDA announces that the agency has sent warning/advisory letters to 14 different companies who have been promoting unregulated products as treatments and even cures to cancer.
"'Consumers should not use these or similar unproven products because they may be unsafe and could prevent a person from seeking an appropriate and potentially life-saving cancer diagnosis or treatment,' said Douglas W. Stearn, director of the Office of Enforcement and Import Operations in the FDA’s Office of Regulatory Affairs. 'We encourage people to remain vigilant whether online or in a store, and avoid purchasing products marketed to treat cancer without any proof they will work. Patients should consult a health care professional about proper prevention, diagnosis and treatment of cancer.'" the release reads.
Most of the "products" in the advisory are vitamin supplements like St. John's Wort, vitamin B2, and vitamin C in various forms. The agency and others have reported on the growing dangers of unregulated supplements across the country as more and more consumers choose to buy these products and don't know the dangers. The companies are listed below, and you can look at the list of individual products here. You can also report any consumer complaints or concerns to the FDA through their MedWatch program.
- AIE Pharmaceuticals, Inc.
- Amazing Sour Sop, Inc.
- BioStar Technology International LLC
- Caudill Seed & Warehouse, Inc.
- Everything Herbs
- Hawk Dok Natural Salve
- Healing Within Products & Services, Inc.
- LiveVantage Corporation
- Nature's Treasure, Inc.
- Oxygen Health Systems LLC
- Sunstone, Inc.
- The Vibrant Health Store LLC dba Dr. Christopher's Herbs
- The Vitamin C Foundation
- CellMark BioPharma LLC
- Landis Revin LLC
- Nathans Natural
© New Kapitall Holdings LLC. All rights reserved. Kapitall Wire is a division of New Kapitall Holdings LLC. Kapitall Generation, LLC is a wholly owned subsidiary of New Kapitall Holdings LLC.
Kapitall Wire offers free cutting edge investing ideas, intended for educational information purposes only. It should not be construed as an offer to buy or sell securities, or any other product or service provided by New Kapitall Holdings, and its affiliate companies.